• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜母细胞瘤动脉内化疗的并发症

Complications of intra-arterial chemotherapy for retinoblastoma.

作者信息

Monroy Jose Efren Gonzalez, Orbach Darren B, VanderVeen Deborah

机构信息

Children's Hospital , Boston, Massachusetts , USA.

出版信息

Semin Ophthalmol. 2014 Sep-Nov;29(5-6):429-33. doi: 10.3109/08820538.2014.959188.

DOI:10.3109/08820538.2014.959188
PMID:25325870
Abstract

INTRODUCTION

The purpose of this paper is to perform a systematic review of the published literature on complications of intra-arterial chemothrapy (IAC) for the treatment of retinoblastoma.

MATERIALS AND METHODS

A literature search was performed using the Pubmed database using the terms. Complications were divided into extraocular and intraocular.

RESULTS

A total of 117 articles were found using this Pubmed search method; 35 articles were selected for review as they describe specifical complications of IAC for retinoblastoma. A variety of extraocular and intraocular complications were reported and discussed.

DISCUSSION

IAC for the treatment of retinoblastoma is a technique that has been gaining popularity in recent years, but is not without complications. Continued research is warranted to further improve current techniques and delivery of chemotherapeutic agents into the eye.

摘要

引言

本文旨在对已发表的关于动脉内化疗(IAC)治疗视网膜母细胞瘤并发症的文献进行系统综述。

材料与方法

使用Pubmed数据库,通过相关检索词进行文献检索。并发症分为眼外并发症和眼内并发症。

结果

使用这种Pubmed检索方法共找到117篇文章;35篇文章被选入综述,因为它们描述了IAC治疗视网膜母细胞瘤的特定并发症。报告并讨论了各种眼外和眼内并发症。

讨论

IAC治疗视网膜母细胞瘤是近年来越来越受欢迎的一种技术,但并非没有并发症。有必要继续开展研究,以进一步改进当前技术,并将化疗药物输送到眼内。

相似文献

1
Complications of intra-arterial chemotherapy for retinoblastoma.视网膜母细胞瘤动脉内化疗的并发症
Semin Ophthalmol. 2014 Sep-Nov;29(5-6):429-33. doi: 10.3109/08820538.2014.959188.
2
Onset and Resolution of Ocular Motor Cranial Nerve Palsies Following the Use of Intra-Arterial Chemotherapy for Retinoblastoma.视网膜母细胞瘤动脉内化疗后动眼神经麻痹的发生与缓解
Semin Ophthalmol. 2025 Aug;40(6):558-563. doi: 10.1080/08820538.2025.2501796. Epub 2025 May 7.
3
The Role of Intravitreal Chemotherapy as an Adjunctive Treatment for Retinoblastoma: A Systematic Review and Single-Arm Meta-Analysis.玻璃体内化疗作为视网膜母细胞瘤辅助治疗的作用:一项系统评价和单臂荟萃分析
Am J Ophthalmol. 2025 May;273:130-140. doi: 10.1016/j.ajo.2024.12.012. Epub 2024 Dec 17.
4
Do's and Don'ts" for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know?视网膜母细胞瘤动脉内化疗的“注意事项”——眼科医生和介入放射科医生需要了解什么?
Indian J Ophthalmol. 2025 Jun 1;73(6):916-919. doi: 10.4103/IJO.IJO_2912_24. Epub 2025 May 28.
5
Effect of intra-arterial chemotherapy drug regimens on globe salvage outcomes of retinoblastoma patients.动脉内化疗药物方案对视网膜母细胞瘤患者眼球挽救结局的影响。
Br J Ophthalmol. 2025 Jul 22;109(8):888-893. doi: 10.1136/bjo-2024-326452.
6
Globe Volume Asymmetry After Intra-arterial Chemotherapy for Retinoblastoma.
J Pediatr Ophthalmol Strabismus. 2025 Jul-Aug;62(4):e46-e50. doi: 10.3928/01913913-20250520-01. Epub 2025 Jul 1.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Ocular pharmacology of topotecan and its activity in retinoblastoma.拓扑替康的眼部药理学及其在视网膜母细胞瘤中的活性。
Retina. 2014 Sep;34(9):1719-27. doi: 10.1097/IAE.0000000000000253.
9
Second Malignant Neoplasms in Long-term Retinoblastoma Survivors: Retrospective Cohort Study of 491 Patients in Turkey.长期视网膜母细胞瘤幸存者的二次恶性肿瘤:土耳其491例患者的回顾性队列研究
J Pediatr Hematol Oncol. 2025 Jul 1;47(5):e161-e167. doi: 10.1097/MPH.0000000000003039. Epub 2025 Apr 21.
10
Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review.评估眼内注射治疗视网膜母细胞瘤后眼外肿瘤扩散的风险:系统评价。
Br J Ophthalmol. 2013 Oct;97(10):1231-6. doi: 10.1136/bjophthalmol-2013-303188. Epub 2013 Jun 5.

引用本文的文献

1
Suprachoroidal Injection of Topotecan for Retinoblastoma: A Preclinical Study.脉络膜上腔注射拓扑替康治疗视网膜母细胞瘤的临床前研究
Ophthalmol Sci. 2025 Jul 4;5(6):100875. doi: 10.1016/j.xops.2025.100875. eCollection 2025 Nov-Dec.
2
A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1).多机构研究探讨视网膜母细胞瘤患儿行眼动脉内化疗的可行性。儿童肿瘤协作组研究(COG ARET12P1)。
Pediatr Blood Cancer. 2024 Jan;71(1):e30718. doi: 10.1002/pbc.30718. Epub 2023 Oct 10.
3
Causes of death and survival analysis for patients with retinoblastoma in Jordan.
约旦视网膜母细胞瘤患者的死因及生存分析
Front Med (Lausanne). 2023 Sep 4;10:1244308. doi: 10.3389/fmed.2023.1244308. eCollection 2023.
4
Pediatric Interventional Neuroradiology: Opportunities and Challenges.小儿介入神经放射学:机遇与挑战
Children (Basel). 2023 Apr 12;10(4):715. doi: 10.3390/children10040715.
5
Atypical Event Profiling of Intra-Arterial Chemotherapy.动脉内化疗的非典型事件剖析
J Vitreoretin Dis. 2022 May 20;6(3):251-254. doi: 10.1177/24741264221083411. eCollection 2022 May-Jun.
6
The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma.交替全身静脉化疗和眼内动脉化疗治疗视网膜母细胞瘤眼球保存的疗效。
Cancer Res Treat. 2023 Jan;55(1):270-278. doi: 10.4143/crt.2021.1537. Epub 2022 May 24.
7
Analysis of Cause-Specific Mortality in Patients with Retinoblastoma.视网膜母细胞瘤患者特定病因死亡率分析
J Ophthalmol. 2022 Mar 4;2022:2470890. doi: 10.1155/2022/2470890. eCollection 2022.
8
Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India.视网膜母细胞瘤的动脉内化疗:来自印度三级中心的四年结果
Ocul Oncol Pathol. 2020 Jan;6(1):66-73. doi: 10.1159/000500010. Epub 2019 Jun 4.
9
Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: Results and short-term complications.单侧晚期眼内视网膜母细胞瘤的动脉内化疗:结果与短期并发症
Medicine (Baltimore). 2018 Oct;97(42):e12676. doi: 10.1097/MD.0000000000012676.